The influenza A virus protein NS1 displays structural polymorphism.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 3993732)

Published in J Virol on January 29, 2014

Authors

Berenice Carrillo1, Jae-Mun Choi, Zachary A Bornholdt, Banumathi Sankaran, Andrew P Rice, B V Venkataram Prasad

Author Affiliations

1: Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.

Articles cited by this

Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01

PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr (2010) 108.52

Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr (2011) 67.55

MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res (2007) 37.31

Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature (1992) 36.50

iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM. Acta Crystallogr D Biol Crystallogr (2011) 18.13

Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology (1998) 9.81

Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med (2002) 9.47

Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2006) 7.29

The multifunctional NS1 protein of influenza A viruses. J Gen Virol (2008) 6.87

Systematic analysis of domain motions in proteins from conformational change: new results on citrate synthase and T4 lysozyme. Proteins (1998) 5.91

Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe (2009) 5.12

Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol (2007) 3.53

The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway. Proc Natl Acad Sci U S A (2006) 3.50

Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma. Cell (2008) 3.43

Influenza research database: an integrated bioinformatics resource for influenza research and surveillance. Influenza Other Respir Viruses (2012) 3.04

Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells. J Virol (1999) 2.65

Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in Vero cells. J Virol (1998) 2.42

Crystal structure of the unique RNA-binding domain of the influenza virus NS1 protein. Nat Struct Biol (1997) 2.41

Multiple alignment comparison of the non-structural genes of influenza A viruses. Virus Res (1998) 2.30

Retracted The NS1 gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses. Virus Res (2004) 2.15

Structural basis for suppression of a host antiviral response by influenza A virus. Proc Natl Acad Sci U S A (2008) 2.02

Nuclear and nucleolar targeting of influenza A virus NS1 protein: striking differences between different virus subtypes. J Virol (2007) 1.92

Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein. J Virol (2010) 1.81

X-ray structure of NS1 from a highly pathogenic H5N1 influenza virus. Nature (2008) 1.77

The H5N1 influenza virus NS genes selected after 1998 enhance virus replication in mammalian cells. J Virol (2007) 1.75

X-ray structure of influenza virus NS1 effector domain. Nat Struct Mol Biol (2006) 1.74

Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. Virology (2005) 1.56

Structure of an avian influenza A virus NS1 protein effector domain. Virology (2008) 1.50

Structural basis for dsRNA recognition by NS1 protein of influenza A virus. Cell Res (2009) 1.48

Properties of H7N7 influenza A virus strain SC35M lacking interferon antagonist NS1 in mice and chickens. J Gen Virol (2007) 1.38

Virulence of H5N1 avian influenza virus enhanced by a 15-nucleotide deletion in the viral nonstructural gene. Virus Genes (2008) 1.36

Influenza a virus polymerase is an integral component of the CPSF30-NS1A protein complex in infected cells. J Virol (2008) 1.35

Structural insights into phosphoinositide 3-kinase activation by the influenza A virus NS1 protein. Proc Natl Acad Sci U S A (2010) 1.34

Influenza A virus strains that circulate in humans differ in the ability of their NS1 proteins to block the activation of IRF3 and interferon-β transcription. Virology (2010) 1.26

CDK/ERK-mediated phosphorylation of the human influenza A virus NS1 protein at threonine-215. Virology (2008) 1.26

The NS segment of an H5N1 highly pathogenic avian influenza virus (HPAIV) is sufficient to alter replication efficiency, cell tropism, and host range of an H7N1 HPAIV. J Virol (2009) 1.20

A Closer Look at the NS1 of Influenza Virus. Viruses (2009) 1.15

The ESEV PDZ-binding motif of the avian influenza A virus NS1 protein protects infected cells from apoptosis by directly targeting Scribble. J Virol (2010) 1.13

Modification of nonstructural protein 1 of influenza A virus by SUMO1. J Virol (2010) 1.13

Structure of NS1A effector domain from the influenza A/Udorn/72 virus. Acta Crystallogr D Biol Crystallogr (2008) 1.10

A transient homotypic interaction model for the influenza A virus NS1 protein effector domain. PLoS One (2011) 1.07

The avian influenza virus NS1 ESEV PDZ binding motif associates with Dlg1 and Scribble to disrupt cellular tight junctions. J Virol (2011) 1.07

Dimer interface of the effector domain of non-structural protein 1 from influenza A virus: an interface with multiple functions. J Biol Chem (2011) 1.03

Roles of the phosphorylation of specific serines and threonines in the NS1 protein of human influenza A viruses. J Virol (2012) 0.98

X-ray structures of NS1 effector domain mutants. Arch Biochem Biophys (2009) 0.92

Strain-specific contribution of NS1-activated phosphoinositide 3-kinase signaling to influenza A virus replication and virulence. J Virol (2012) 0.85

Contribution of NS1 effector domain dimerization to influenza A virus replication and virulence. J Virol (2012) 0.85

SUMOylation affects the interferon blocking activity of the influenza A nonstructural protein NS1 without affecting its stability or cellular localization. J Virol (2013) 0.85

Reduction of density-modification bias by β correction. Acta Crystallogr D Biol Crystallogr (2011) 0.82

Conservation of a crystallographic interface suggests a role for β-sheet augmentation in influenza virus NS1 multifunctionality. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.79

Articles by these authors

Structure and rearrangements in the carboxy-terminal region of SpIH channels. Structure (2007) 3.09

Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc Natl Acad Sci U S A (2008) 2.54

Structural requirements for the assembly of Norwalk virus-like particles. J Virol (2002) 2.38

X-ray structure of a native calicivirus: structural insights into antigenic diversity and host specificity. Proc Natl Acad Sci U S A (2006) 2.09

miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1. PLoS Pathog (2009) 1.94

Visualizing the ATPase cycle in a protein disaggregating machine: structural basis for substrate binding by ClpB. Mol Cell (2007) 1.82

Inter- and intragenus structural variations in caliciviruses and their functional implications. J Virol (2004) 1.79

X-ray structure of NS1 from a highly pathogenic H5N1 influenza virus. Nature (2008) 1.77

X-ray structure of influenza virus NS1 effector domain. Nat Struct Mol Biol (2006) 1.74

Evolutionary trace residues in noroviruses: importance in receptor binding, antigenicity, virion assembly, and strain diversity. J Virol (2005) 1.71

Selective inhibitors of histone methyltransferase DOT1L: design, synthesis, and crystallographic studies. J Am Chem Soc (2011) 1.66

Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature (2012) 1.65

Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution. J Virol (2011) 1.53

Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression. Proc Natl Acad Sci U S A (2009) 1.48

Rotavirus architecture at subnanometer resolution. J Virol (2008) 1.48

Structural basis of Fic-mediated adenylylation. Nat Struct Mol Biol (2010) 1.44

Structure of the carboxy-terminal region of a KCNH channel. Nature (2012) 1.41

Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb. J Clin Invest (2002) 1.34

Regulation of cyclin T1 and HIV-1 Replication by microRNAs in resting CD4+ T lymphocytes. J Virol (2011) 1.32

Emerging themes in rotavirus cell entry, genome organization, transcription and replication. Virus Res (2004) 1.31

Rotavirus proteins: structure and assembly. Curr Top Microbiol Immunol (2006) 1.30

Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function. J Virol (2002) 1.29

Norwalk virus assembly and stability monitored by mass spectrometry. Mol Cell Proteomics (2010) 1.26

Rotavirus protein involved in genome replication and packaging exhibits a HIT-like fold. Nature (2002) 1.24

Phosphatase PPM1A regulates phosphorylation of Thr-186 in the Cdk9 T-loop. J Biol Chem (2008) 1.23

Interactions between the inner and outer capsids of bluetongue virus. J Virol (2004) 1.22

X-ray structures of the N- and C-terminal domains of a coronavirus nucleocapsid protein: implications for nucleocapsid formation. J Virol (2006) 1.22

The ebola virus interferon antagonist VP24 directly binds STAT1 and has a novel, pyramidal fold. PLoS Pathog (2012) 1.20

Cryoelectron microscopy structures of rotavirus NSP2-NSP5 and NSP2-RNA complexes: implications for genome replication. J Virol (2006) 1.20

Characterization of Cdk9 T-loop phosphorylation in resting and activated CD4(+) T lymphocytes. J Leukoc Biol (2009) 1.19

Effects of prostratin on Cyclin T1/P-TEFb function and the gene expression profile in primary resting CD4+ T cells. Retrovirology (2006) 1.17

High-resolution molecular and antigen structure of the VP8* core of a sialic acid-independent human rotavirus strain. J Virol (2006) 1.16

Identification of LKLF-regulated genes in quiescent CD4+ T lymphocytes. Mol Immunol (2005) 1.16

A new crucial protein interaction element that targets the adenovirus E4-ORF1 oncoprotein to membrane vesicles. J Virol (2007) 1.15

The ESEV PDZ-binding motif of the avian influenza A virus NS1 protein protects infected cells from apoptosis by directly targeting Scribble. J Virol (2010) 1.13

Structure of an As(III) S-adenosylmethionine methyltransferase: insights into the mechanism of arsenic biotransformation. Biochemistry (2012) 1.13

Structural changes common to catalysis in the Tpx peroxiredoxin subfamily. J Mol Biol (2009) 1.12

Emerging theme: cellular PDZ proteins as common targets of pathogenic viruses. J Virol (2011) 1.12

Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation activity. Virology (2009) 1.09

Functional maturation of the human antibody response to rotavirus. J Immunol (2008) 1.09

Cyclin T1 and CDK9 T-loop phosphorylation are downregulated during establishment of HIV-1 latency in primary resting memory CD4+ T cells. J Virol (2012) 1.08

Role of the histidine triad-like motif in nucleotide hydrolysis by the rotavirus RNA-packaging protein NSP2. J Biol Chem (2003) 1.07

The avian influenza virus NS1 ESEV PDZ binding motif associates with Dlg1 and Scribble to disrupt cellular tight junctions. J Virol (2011) 1.07

Interleukin-10 inhibits HIV-1 LTR-directed gene expression in human macrophages through the induction of cyclin T1 proteolysis. Virology (2006) 1.06

Structure-function analysis of rotavirus NSP2 octamer by using a novel complementation system. J Virol (2006) 1.06

Inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase by lipophilic phosphonates: SAR, QSAR, and crystallographic studies. J Med Chem (2011) 1.06

Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase. ACS Med Chem Lett (2013) 1.05

Cyclin T1 but not cyclin T2a is induced by a post-transcriptional mechanism in PAMP-activated monocyte-derived macrophages. J Leukoc Biol (2005) 1.04

Crystal structure of Marburg virus VP24. J Virol (2014) 1.04

Increased association of 7SK snRNA with Tat cofactor P-TEFb following activation of peripheral blood lymphocytes. AIDS (2003) 1.03

Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonism. PLoS Pathog (2012) 1.03

Induction of the HIV-1 Tat co-factor cyclin T1 during monocyte differentiation is required for the regulated expression of a large portion of cellular mRNAs. Retrovirology (2006) 1.03

Crystallization and preliminary X-ray crystallographic analysis of the ArsM arsenic(III) S-adenosylmethionine methyltransferase. Acta Crystallogr Sect F Struct Biol Cryst Commun (2010) 1.01

Cyclin T1-dependent genes in activated CD4 T and macrophage cell lines appear enriched in HIV-1 co-factors. PLoS One (2008) 1.01

Crystal structure of cGMP-dependent protein kinase reveals novel site of interchain communication. Structure (2011) 1.01

T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes. J Cell Physiol (2010) 1.00

Crystallization and preliminary crystallographic analysis of San Miguel sea lion virus: an animal calicivirus. J Struct Biol (2003) 1.00

Rotavirus non-structural proteins: structure and function. Curr Opin Virol (2012) 0.99

siRNA depletion of 7SK snRNA induces apoptosis but does not affect expression of the HIV-1 LTR or P-TEFb-dependent cellular genes. J Cell Physiol (2005) 0.99

Human immunodeficiency virus type 1 infection induces cyclin T1 expression in macrophages. J Virol (2004) 0.99

Conformational changes in the capsid of a calicivirus upon interaction with its functional receptor. J Virol (2010) 0.99

pH-induced conformational change of the rotavirus VP4 spike: implications for cell entry and antibody neutralization. J Virol (2005) 0.99

Structural basis of substrate specificity and protease inhibition in Norwalk virus. J Virol (2013) 0.98

miR-132 enhances HIV-1 replication. Virology (2013) 0.98

Antibody responses to norovirus genogroup GI.1 and GII.4 proteases in volunteers administered Norwalk virus. Clin Vaccine Immunol (2012) 0.97

The VP8* domain of neonatal rotavirus strain G10P[11] binds to type II precursor glycans. J Virol (2013) 0.97

Integration of human immunodeficiency virus type 1 in untreated infection occurs preferentially within genes. J Virol (2006) 0.95

A crystal structure of the cyclic GMP-dependent protein kinase I{beta} dimerization/docking domain reveals molecular details of isoform-specific anchoring. J Biol Chem (2010) 0.94

The ebolavirus VP24 interferon antagonist: know your enemy. Virulence (2012) 0.94

Structures of rotavirus reassortants demonstrate correlation of altered conformation of the VP4 spike and expression of unexpected VP4-associated phenotypes. J Virol (2003) 0.93

The ClpB/Hsp104 molecular chaperone-a protein disaggregating machine. J Struct Biol (2004) 0.93

Rotavirus cell entry. Curr Top Microbiol Immunol (2010) 0.93

Structural basis for 2'-5'-oligoadenylate binding and enzyme activity of a viral RNase L antagonist. J Virol (2015) 0.92

A conserved Glu-Arg salt bridge connects coevolved motifs that define the eukaryotic protein kinase fold. J Mol Biol (2011) 0.92

Cdk9 T-loop phosphorylation is regulated by the calcium signaling pathway. J Cell Physiol (2012) 0.92

Neutron diffraction reveals hydrogen bonds critical for cGMP-selective activation: insights for cGMP-dependent protein kinase agonist design. Biochemistry (2014) 0.91

MicroRNA-mediated restriction of HIV-1 in resting CD4+ T cells and monocytes. Viruses (2012) 0.90

Mini ways to stop a virus: microRNAs and HIV-1 replication. Future Virol (2011) 0.90

Ebolavirus VP35 coats the backbone of double-stranded RNA for interferon antagonism. J Virol (2013) 0.90

Structural Basis for Different Substrate Profiles of Two Closely Related Class D β-Lactamases and Their Inhibition by Halogens. Biochemistry (2015) 0.90

Structural and biochemical evidence that a TEM-1 beta-lactamase N170G active site mutant acts via substrate-assisted catalysis. J Biol Chem (2009) 0.90

Cysteine dioxygenase structures from pH4 to 9: consistent cys-persulfenate formation at intermediate pH and a Cys-bound enzyme at higher pH. J Mol Biol (2013) 0.90

Molecular basis for the catalytic specificity of the CTX-M extended-spectrum β-lactamases. Biochemistry (2014) 0.90

Crystallographic and biochemical analysis of rotavirus NSP2 with nucleotides reveals a nucleoside diphosphate kinase-like activity. J Virol (2007) 0.89

Prestress strengthens the shell of Norwalk virus nanoparticles. Nano Lett (2011) 0.89

X-ray crystal structure of the UCS domain-containing UNC-45 myosin chaperone from Drosophila melanogaster. Structure (2011) 0.89

Structural insights into the functions of TBK1 in innate antimicrobial immunity. Structure (2013) 0.89

Structure of yeast regulatory subunit: a glimpse into the evolution of PKA signaling. Structure (2010) 0.88

55K isoform of CDK9 associates with Ku70 and is involved in DNA repair. Biochem Biophys Res Commun (2010) 0.88

Phosphatase PPM1A negatively regulates P-TEFb function in resting CD4(+) T cells and inhibits HIV-1 gene expression. Retrovirology (2012) 0.88

Crystallographic Analysis of Rotavirus NSP2-RNA Complex Reveals Specific Recognition of 5' GG Sequence for RTPase Activity. J Virol (2012) 0.86

Structural analysis of determinants of histo-blood group antigen binding specificity in genogroup I noroviruses. J Virol (2014) 0.86

Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas. PLoS One (2011) 0.86

Isolation and characterization of the human DC-SIGN and DC-SIGNR promoters. Gene (2003) 0.86